|
Sign In to gain access to subscriptions and/or personal tools.
|
HIV dementia: the role of the basal ganglia and dopaminergic systems
Joseph R. Berger
Departments of Neurology and Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky
Gabriele Arendt
Department of Neurology, Heinrich Heine University of Duesseldorf, Duesseldorf, Germany
The clinical features of human immunodefiency virus (HIV) dementia exhibit the hallmarks of a subcortical dementia. These features include psychomotor slowing, apathy, bradykinesia and altered posture and gait similar to those observed in advanced Parkinson's disease. The dementia has the hallmarks attributed to subcortical dementia. The exquisite sensitivity of many of these patients to dopamine receptor blockade suggested a profound and, perhaps, selective abnormality of striatal dopaminergic systems. Additional investigations, electrophysiological, pathological, virological, metabolic and radiological studies, indicate that the basal ganglia are a major target of HIV infection. In this review, we describe the evidence for involvement of basal ganglia and, in particular, the dopaminergic systems, in HIV dementia. We also suggest novel therapeutic strategies that may be beneficial in the treatment of this disorder.
Key Words: AIDS basal ganglia dementia dopamine HIV Parkinsonism striatum
Journal of Psychopharmacology, Vol. 14, No. 3,
214-221 (2000)
DOI: 10.1177/026988110001400304

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M SARAVANAN and I W TURNBULL
Brain: non-infective and non-neoplastic manifestations of HIV
Br. J. Radiol.,
November 1, 2009;
82(983):
956 - 965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Maingat, P. Vivithanaporn, Y. Zhu, A. Taylor, G. Baker, K. Pearson, and C. Power
Neurobehavioral Performance in Feline Immunodeficiency Virus Infection: Integrated Analysis of Viral Burden, Neuroinflammation, and Neuronal Injury in Cortex
J. Neurosci.,
July 1, 2009;
29(26):
8429 - 8437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhu, C. F. Mactutus, D. R. Wallace, and R. M. Booze
HIV-1 Tat Protein-Induced Rapid and Reversible Decrease in [3H]Dopamine Uptake: Dissociation of [3H]Dopamine Uptake and [3H]2{beta}-Carbomethoxy-3-{beta}-(4-fluorophenyl)tropane (WIN 35,428) Binding in Rat Striatal Synaptosomes
J. Pharmacol. Exp. Ther.,
June 1, 2009;
329(3):
1071 - 1083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cs. Horvath, G. G. Kovacs, V. Kovari, K. Majtenyi, Y. L. Hurd, and E. Keller
Heroin Abuse Is Characterized by Discrete Mesolimbic Dopamine and Opioid Abnormalities and Exaggerated Nuclear Receptor-Related 1 Transcriptional Decline with Age
J. Neurosci.,
December 5, 2007;
27(49):
13371 - 13375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. B. Castelo, M. G. Courtney, R. J. Melrose, and C. E. Stern
Putamen Hypertrophy in Nondemented Patients With Human Immunodeficiency Virus Infection and Cognitive Compromise
Arch Neurol,
September 1, 2007;
64(9):
1275 - 1280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fitting, R. M. Booze, and C. F. Mactutus
Neonatal Intrahippocampal Glycoprotein 120 Injection: The Role of Dopaminergic Alterations in Prepulse Inhibition in Adult Rats
J. Pharmacol. Exp. Ther.,
September 1, 2006;
318(3):
1352 - 1358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Sui, S. Fan, L. Sniderhan, E. Reisinger, A. Litzburg, G. Schifitto, H. A. Gelbard, S. Dewhurst, and S. B. Maggirwar
Inhibition of Mixed Lineage Kinase 3 Prevents HIV-1 Tat-Mediated Neurotoxicity and Monocyte Activation
J. Immunol.,
July 1, 2006;
177(1):
702 - 711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Panavas, E. Serviene, J. Brasher, and P. D. Nagy
Yeast genome-wide screen reveals dissimilar sets of host genes affecting replication of RNA viruses
PNAS,
May 17, 2005;
102(20):
7326 - 7331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. von Giesen, B. A. Haslinger, S. Rohe, H. Koller, and G. Arendt
HIV Dementia Scale and Psychomotor Slowing--The Best Methods in Screening for Neuro-AIDS
J Neuropsychiatry Clin Neurosci,
May 1, 2005;
17(2):
185 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Paul, T. P. Flanigan, K. Tashima, R. Cohen, J. Lawrence, E. Alt, D. Tate, C. Ritchie, and C. Hinkin
Apathy Correlates With Cognitive Function But Not CD4 Status in Patients With Human Immunodeficiency Virus
J Neuropsychiatry Clin Neurosci,
February 1, 2005;
17(1):
114 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. MORDELET, K. KISSA, A. CRESSANT, F. GRAY, S. OZDEN, C. VIDAL, P. CHARNEAU, and S. GRANON
Histopathological and cognitive defects induced by Nef in the brain
FASEB J,
December 1, 2004;
18(15):
1851 - 1861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wenserski, H.-J. von Giesen, H.-J. Wittsack, A. Aulich, and G. Arendt
Human Immmunodeficiency Virus 1-associated Minor Motor Disorders: Perfusion-weighted MR Imaging and H MR Spectroscopy
Radiology,
July 1, 2003;
228(1):
185 - 192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Boven, N. Vergnolle, S. D. Henry, C. Silva, Y. Imai, J. Holden, K. Warren, M. D. Hollenberg, and C. Power
Up-Regulation of Proteinase-Activated Receptor 1 Expression in Astrocytes During HIV Encephalitis
J. Immunol.,
March 1, 2003;
170(5):
2638 - 2646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. von Giesen, H.-J. Wittsack, F. Wenserski, H. Koller, H. Hefter, and G. Arendt
Basal Ganglia Metabolite Abnormalities in Minor Motor Disorders Associated With Human Immunodeficiency Virus Type 1
Arch Neurol,
August 1, 2001;
58(8):
1281 - 1286.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|